ECSP12012279A - Comprimido de desintegración por vía oral que contiene acarbosa - Google Patents
Comprimido de desintegración por vía oral que contiene acarbosaInfo
- Publication number
- ECSP12012279A ECSP12012279A ECSP12012279A ECSP12012279A EC SP12012279 A ECSP12012279 A EC SP12012279A EC SP12012279 A ECSP12012279 A EC SP12012279A EC SP12012279 A ECSP12012279 A EC SP12012279A
- Authority
- EC
- Ecuador
- Prior art keywords
- compressed
- decrease
- oral route
- acarbose
- route containing
- Prior art date
Links
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 title abstract 3
- 229960002632 acarbose Drugs 0.000 title abstract 3
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 title abstract 3
- 102000004366 Glucosidases Human genes 0.000 abstract 1
- 108010056771 Glucosidases Proteins 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Era un objeto de la presente invención proporcionar un comprimido de desintegración por vía oral (ODT) para el inhibidor de la glucosidasa acarbosa. El objetivo se consigue con un comprimido de desintegración por vía oral que contiene un 1-30 % de acarbosa y un 40-90 % de vehículo soluble en agua. Con el fin de obtener las propiedades deseadas, se tienen que compactar previamente los ingredientes y mezclar previamente con un vehículo insoluble.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10161114 | 2010-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP12012279A true ECSP12012279A (es) | 2012-11-30 |
Family
ID=44344015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP12012279 ECSP12012279A (es) | 2010-04-27 | 2012-10-26 | Comprimido de desintegración por vía oral que contiene acarbosa |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20130131003A1 (es) |
| EP (1) | EP2563329B1 (es) |
| JP (1) | JP5944378B2 (es) |
| KR (1) | KR101788350B1 (es) |
| CN (2) | CN102905687A (es) |
| AU (1) | AU2011247642C1 (es) |
| BR (1) | BR112012027303A2 (es) |
| CA (1) | CA2797365A1 (es) |
| CL (1) | CL2012003011A1 (es) |
| CO (1) | CO6640213A2 (es) |
| CR (1) | CR20120548A (es) |
| CU (1) | CU20120152A7 (es) |
| DO (1) | DOP2012000277A (es) |
| EC (1) | ECSP12012279A (es) |
| ES (1) | ES2623025T3 (es) |
| GT (1) | GT201200290A (es) |
| IL (1) | IL222368B (es) |
| MX (1) | MX348865B (es) |
| MY (1) | MY179724A (es) |
| NZ (1) | NZ603199A (es) |
| PE (1) | PE20130403A1 (es) |
| PH (1) | PH12012502139A1 (es) |
| SG (2) | SG184851A1 (es) |
| SI (1) | SI2563329T1 (es) |
| TW (1) | TWI556823B (es) |
| UA (1) | UA111155C2 (es) |
| WO (1) | WO2011134962A2 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201100150A2 (tr) * | 2011-01-06 | 2012-07-23 | Bi̇lgi̇ç Mahmut | Suda çözünür dozaj formları |
| WO2013115741A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Pharmaceutical compositions comprising alpha-glucosidase inhibitor |
| WO2013115738A1 (en) * | 2012-01-31 | 2013-08-08 | Mahmut Bilgic | Micronized acarbose |
| CA2922849A1 (en) | 2012-08-31 | 2014-03-06 | Ixchel Pharma, Llc | Agents useful for treating obesity, diabetes and related disorders |
| CN104013590A (zh) * | 2014-05-09 | 2014-09-03 | 万特制药(海南)有限公司 | 一种含阿卡波糖的药物组合物及其制备方法 |
| KR101937069B1 (ko) | 2014-12-17 | 2019-04-03 | 엠프로스 파마 악티에볼라그 | 비만 및 관련 대사 장애의 치료를 위한 오를리스타트 및 아카르보스의 변형 방출형 조성물 |
| CN105213341A (zh) * | 2015-10-29 | 2016-01-06 | 无锡福祈制药有限公司 | 一种阿卡波糖片及其制备方法 |
| CN113081984B (zh) * | 2021-04-19 | 2023-06-02 | 北京阳光诺和药物研究股份有限公司 | 一种阿卡波糖口崩片及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134591A1 (de) * | 1981-09-01 | 1983-03-10 | Bayer Ag, 5090 Leverkusen | Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren |
| JPH10182687A (ja) * | 1996-10-21 | 1998-07-07 | Bayer Yakuhin Kk | アカルボースの貯蔵安定化法 |
| DE19802700A1 (de) * | 1998-01-24 | 1999-07-29 | Bayer Ag | Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält |
| US20040081697A1 (en) * | 1998-11-12 | 2004-04-29 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| KR100682836B1 (ko) * | 2004-12-06 | 2007-02-15 | 엘지전자 주식회사 | 유기 전계 발광 소자 |
| US20060229261A1 (en) * | 2005-04-12 | 2006-10-12 | John Devane | Acarbose methods and formulations for treating chronic constipation |
| MY157620A (en) * | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
| WO2007099908A1 (ja) * | 2006-02-27 | 2007-09-07 | Matsushita Electric Industrial Co., Ltd. | ウェアラブル端末、および、携帯撮像収音装置、およびそれらを実現する装置、方法、プログラム |
| FI20070521A7 (fi) * | 2006-11-10 | 2008-05-11 | Atacama Labs Oy | Rakeita, tabletteja ja rakeistusmenetelmä |
| CN101411715B (zh) * | 2007-10-19 | 2012-03-28 | 杭州华东医药集团生物工程研究所有限公司 | 含有阿卡波糖的药物组合物 |
| JP5291324B2 (ja) * | 2007-11-01 | 2013-09-18 | 沢井製薬株式会社 | 口腔内崩壊錠 |
| JP2009114113A (ja) * | 2007-11-06 | 2009-05-28 | Nipro Corp | 口腔内崩壊錠及びその製造方法 |
| BRPI0820861A2 (pt) * | 2007-12-08 | 2015-06-16 | Bayer Schering Pharma Ag | Comprimido oral dispersível |
| RU2524638C2 (ru) * | 2007-12-21 | 2014-07-27 | Апталис Фарматех Инк. | Орально распадающиеся таблеточные композиции темазепама |
| EP2299982B1 (de) * | 2008-06-20 | 2018-04-04 | Merck Patent GmbH | Direkt verpressbare und schnell zerfallende tablettenmatirx |
-
2011
- 2011-04-26 AU AU2011247642A patent/AU2011247642C1/en not_active Ceased
- 2011-04-26 CA CA2797365A patent/CA2797365A1/en not_active Abandoned
- 2011-04-26 US US13/643,929 patent/US20130131003A1/en not_active Abandoned
- 2011-04-26 MY MYPI2012700818A patent/MY179724A/en unknown
- 2011-04-26 SG SG2012076147A patent/SG184851A1/en unknown
- 2011-04-26 CN CN2011800205487A patent/CN102905687A/zh active Pending
- 2011-04-26 CN CN201610934162.1A patent/CN106924199A/zh active Pending
- 2011-04-26 SG SG10201505844WA patent/SG10201505844WA/en unknown
- 2011-04-26 SI SI201131170A patent/SI2563329T1/sl unknown
- 2011-04-26 ES ES11716264.4T patent/ES2623025T3/es active Active
- 2011-04-26 PE PE2012002079A patent/PE20130403A1/es not_active Application Discontinuation
- 2011-04-26 PH PH1/2012/502139A patent/PH12012502139A1/en unknown
- 2011-04-26 MX MX2012012459A patent/MX348865B/es active IP Right Grant
- 2011-04-26 WO PCT/EP2011/056587 patent/WO2011134962A2/en not_active Ceased
- 2011-04-26 UA UAA201213526A patent/UA111155C2/uk unknown
- 2011-04-26 EP EP11716264.4A patent/EP2563329B1/en not_active Not-in-force
- 2011-04-26 TW TW100114368A patent/TWI556823B/zh not_active IP Right Cessation
- 2011-04-26 KR KR1020127028046A patent/KR101788350B1/ko not_active Expired - Fee Related
- 2011-04-26 BR BR112012027303A patent/BR112012027303A2/pt not_active IP Right Cessation
- 2011-04-26 JP JP2013506633A patent/JP5944378B2/ja not_active Expired - Fee Related
- 2011-04-26 NZ NZ603199A patent/NZ603199A/en not_active IP Right Cessation
-
2012
- 2012-10-11 IL IL222368A patent/IL222368B/en active IP Right Grant
- 2012-10-25 CU CU2012000152A patent/CU20120152A7/es unknown
- 2012-10-26 GT GT201200290A patent/GT201200290A/es unknown
- 2012-10-26 DO DO2012000277A patent/DOP2012000277A/es unknown
- 2012-10-26 EC ECSP12012279 patent/ECSP12012279A/es unknown
- 2012-10-26 CO CO12192234A patent/CO6640213A2/es not_active Application Discontinuation
- 2012-10-26 CR CR20120548A patent/CR20120548A/es unknown
- 2012-10-26 CL CL2012003011A patent/CL2012003011A1/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP12012279A (es) | Comprimido de desintegración por vía oral que contiene acarbosa | |
| AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
| CO6771428A2 (es) | Composición efervescente en forma sólida para uso en aplicaciones vaginales para el tratamiento de infecciones vaginales | |
| ECSP13012715A (es) | Método para producir preparados farmacéuticos con contenido de ibp | |
| GT201300137A (es) | Derivados de imidazo [1,2-b] piridazina e imidazo [4,5-b] piridina como inhibidores de jak | |
| CO6410279A2 (es) | Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente. | |
| GT201300266A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
| GT201200165A (es) | Triazolopiridinas | |
| CR20130001A (es) | Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica | |
| EA201291372A1 (ru) | Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия | |
| CR20140567A (es) | Formulaciones y métodos para la administración vaginal de antiprogestinas | |
| CR20150367A (es) | Compuestos químicos | |
| CL2016000510A1 (es) | Composiciones para comprimidos bucodispersables que contienen corticosteroides para esofagitis eosinofílica | |
| WO2012141971A3 (en) | Methods and compositions for rejuvenation and expansion of stem cells | |
| BR112015008912A2 (pt) | composições solidificáveis compreendendo volastonita e pedra-pomes e métodos de uso | |
| CO7091174A2 (es) | Compuestos triazolo como inhibidores de pde10 | |
| TR201907136T4 (tr) | Fertigasyon bileşimi ve fertigasyona yönelik yöntem. | |
| PE20161228A1 (es) | Composiciones y metodos que se relacionan a un hidrogel de polimero oclusivo | |
| CR20120461A (es) | Hidrato del hidrobromuro de agomelatina y preparación de éste | |
| NI201300100A (es) | Derivados de tieno [2, 3-d] pirimidina y su uso para tratar arritmias | |
| NZ715615A (en) | Pharmaceutical compositions of ranolazine and dronedarone | |
| MX2015006054A (es) | Enemas. | |
| PE20151432A1 (es) | Formulaciones de lorazepam de liberacion sostenida | |
| PL2445486T3 (pl) | Tabletki z ibuprofenem sodowym i sposoby wytwarzania kompozycji farmaceutycznych zawierających ibuprofen sodowy | |
| CO6640328A2 (es) | Composición farmacéutica que comprende drospirenona y kit anticonceptivo |